ES2651312T3 - Derivados de N-acilhidrazona para un fármaco inhibidor selectivo de células T y contra la neoplasia linfoide - Google Patents
Derivados de N-acilhidrazona para un fármaco inhibidor selectivo de células T y contra la neoplasia linfoide Download PDFInfo
- Publication number
- ES2651312T3 ES2651312T3 ES13833207.7T ES13833207T ES2651312T3 ES 2651312 T3 ES2651312 T3 ES 2651312T3 ES 13833207 T ES13833207 T ES 13833207T ES 2651312 T3 ES2651312 T3 ES 2651312T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- mmol
- acetohydrazide
- synthesis
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010028980 Neoplasm Diseases 0.000 title description 9
- 230000009826 neoplastic cell growth Effects 0.000 title description 6
- 101000935814 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Periplasmic beta-glucosidase Proteins 0.000 title description 2
- 229940123155 T cell inhibitor Drugs 0.000 title description 2
- 229940079593 drug Drugs 0.000 title description 2
- 239000003814 drug Substances 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 abstract description 341
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 10
- 150000003839 salts Chemical class 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 240
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 147
- 230000015572 biosynthetic process Effects 0.000 description 139
- 238000003786 synthesis reaction Methods 0.000 description 139
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 135
- 238000006243 chemical reaction Methods 0.000 description 119
- 238000003756 stirring Methods 0.000 description 116
- 239000011541 reaction mixture Substances 0.000 description 101
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 92
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 78
- 238000004440 column chromatography Methods 0.000 description 67
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 66
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 238000005160 1H NMR spectroscopy Methods 0.000 description 43
- 239000007787 solid Substances 0.000 description 41
- 239000012044 organic layer Substances 0.000 description 38
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 33
- 235000019341 magnesium sulphate Nutrition 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 32
- -1 (E) -N ’- ((1H-indole-4-yl) methylene) -N- (2-hydroxyethyl) -2- (mesyloxy) acetohydrazide Chemical compound 0.000 description 31
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 29
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 28
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 28
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 25
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 24
- 229910000024 caesium carbonate Inorganic materials 0.000 description 24
- 238000010992 reflux Methods 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 23
- JFDDFGLNZWNJTK-UHFFFAOYSA-N indole-4-carbaldehyde Chemical compound O=CC1=CC=CC2=C1C=CN2 JFDDFGLNZWNJTK-UHFFFAOYSA-N 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 239000012141 concentrate Substances 0.000 description 20
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 description 19
- 210000001744 T-lymphocyte Anatomy 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 18
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 18
- VSPBWOAEHQDXRD-UHFFFAOYSA-N 1h-indole-6-carbaldehyde Chemical compound O=CC1=CC=C2C=CNC2=C1 VSPBWOAEHQDXRD-UHFFFAOYSA-N 0.000 description 16
- 208000034578 Multiple myelomas Diseases 0.000 description 15
- 206010035226 Plasma cell myeloma Diseases 0.000 description 15
- OFLXLNCGODUUOT-UHFFFAOYSA-N acetohydrazide Chemical compound C\C(O)=N\N OFLXLNCGODUUOT-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- 239000000741 silica gel Substances 0.000 description 11
- 229910002027 silica gel Inorganic materials 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 9
- 230000006907 apoptotic process Effects 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- 208000009329 Graft vs Host Disease Diseases 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 208000024908 graft versus host disease Diseases 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 7
- 239000012979 RPMI medium Substances 0.000 description 7
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 7
- 201000011186 acute T cell leukemia Diseases 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 208000032839 leukemia Diseases 0.000 description 6
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 6
- 201000006417 multiple sclerosis Diseases 0.000 description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- BHMPIDKAZJPIAU-UHFFFAOYSA-N 2,4-dimethyl-6-(oxolan-2-yl)phenol Chemical compound CC1=CC(C)=C(O)C(C2OCCC2)=C1 BHMPIDKAZJPIAU-UHFFFAOYSA-N 0.000 description 5
- WMHZZTVZKJGMMZ-UHFFFAOYSA-N 2,6-dimethyl-4-(oxolan-3-yl)phenol Chemical compound CC1=C(O)C(C)=CC(C2COCC2)=C1 WMHZZTVZKJGMMZ-UHFFFAOYSA-N 0.000 description 5
- FTMDWLADHNMIAO-UHFFFAOYSA-N 2-(furan-3-yl)-6-methylphenol Chemical compound CC1=CC=CC(C2=COC=C2)=C1O FTMDWLADHNMIAO-UHFFFAOYSA-N 0.000 description 5
- YNGMHHHNZYXBNT-UHFFFAOYSA-N 2-(furan-3-yl)pyridin-3-ol Chemical compound OC1=CC=CN=C1C1=COC=C1 YNGMHHHNZYXBNT-UHFFFAOYSA-N 0.000 description 5
- HFNVCNKPIFBWIZ-UHFFFAOYSA-N 2-pyrrolidin-1-ylpyridin-3-ol Chemical compound OC1=CC=CN=C1N1CCCC1 HFNVCNKPIFBWIZ-UHFFFAOYSA-N 0.000 description 5
- FRHBEPSFCCHBEL-UHFFFAOYSA-N 4-fluoro-2-methyl-6-(oxolan-3-yl)phenol Chemical compound CC1=CC(F)=CC(C2COCC2)=C1O FRHBEPSFCCHBEL-UHFFFAOYSA-N 0.000 description 5
- 231100000111 LD50 Toxicity 0.000 description 5
- 206010025323 Lymphomas Diseases 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- 229960000556 fingolimod Drugs 0.000 description 5
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- IMRIARQZPKNHKZ-UHFFFAOYSA-N 2-(2,3-dimethylphenoxy)acetohydrazide Chemical compound CC1=CC=CC(OCC(=O)NN)=C1C IMRIARQZPKNHKZ-UHFFFAOYSA-N 0.000 description 4
- SFXSJLJPOLAHQT-UHFFFAOYSA-N 2-(2,6-dimethyl-4-pyridin-2-ylphenoxy)acetohydrazide Chemical compound CC1=C(OCC(=O)NN)C(C)=CC(C=2N=CC=CC=2)=C1 SFXSJLJPOLAHQT-UHFFFAOYSA-N 0.000 description 4
- SDXRWLZNJUBJBZ-UHFFFAOYSA-N 2-(4-bromo-2,6-dimethylphenoxy)acetohydrazide Chemical compound CC1=CC(Br)=CC(C)=C1OCC(=O)NN SDXRWLZNJUBJBZ-UHFFFAOYSA-N 0.000 description 4
- CAEHYNWREUFEML-UHFFFAOYSA-N 2-[4-(furan-3-yl)-2,6-dimethylphenoxy]acetohydrazide Chemical compound CC1=C(OCC(=O)NN)C(C)=CC(C2=COC=C2)=C1 CAEHYNWREUFEML-UHFFFAOYSA-N 0.000 description 4
- YOKOHOYQNMLTCN-UHFFFAOYSA-N 2-[4-fluoro-2-methyl-6-(oxolan-3-yl)phenoxy]acetohydrazide Chemical compound CC1=CC(F)=CC(C2COCC2)=C1OCC(=O)NN YOKOHOYQNMLTCN-UHFFFAOYSA-N 0.000 description 4
- JBXIAFBIDZKQDU-UHFFFAOYSA-N 2-pyridin-3-ylphenol Chemical compound OC1=CC=CC=C1C1=CC=CN=C1 JBXIAFBIDZKQDU-UHFFFAOYSA-N 0.000 description 4
- BTODDHHYEXAUQK-UHFFFAOYSA-N 4-(furan-3-yl)-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C2=COC=C2)=C1 BTODDHHYEXAUQK-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- RDGQJSQBUADOSA-UHFFFAOYSA-N 4-fluoro-2-(furan-3-yl)-6-methylphenol Chemical compound CC1=CC(F)=CC(C2=COC=C2)=C1O RDGQJSQBUADOSA-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 4
- 230000000961 alloantigen Effects 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000002491 encephalomyelitis Diseases 0.000 description 4
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 4
- OLNJUISKUQQNIM-UHFFFAOYSA-N indole-3-carbaldehyde Chemical compound C1=CC=C2C(C=O)=CNC2=C1 OLNJUISKUQQNIM-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- YQVBYZVNRUTARY-UHFFFAOYSA-N methyl 2-(4-fluoro-2-methylphenoxy)acetate Chemical compound COC(=O)COC1=CC=C(F)C=C1C YQVBYZVNRUTARY-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BOKIIKHXAALGHV-UHFFFAOYSA-N n-(2-hydrazinyl-2-oxoethyl)methanesulfonamide Chemical compound CS(=O)(=O)NCC(=O)NN BOKIIKHXAALGHV-UHFFFAOYSA-N 0.000 description 4
- 229960001967 tacrolimus Drugs 0.000 description 4
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- IPLIJGFOWLSTDC-UHFFFAOYSA-N 2,4-dimethyl-6-(oxolan-3-yl)phenol Chemical compound CC1=CC(C)=C(O)C(C2COCC2)=C1 IPLIJGFOWLSTDC-UHFFFAOYSA-N 0.000 description 3
- DLZPXTDIXNGPNS-UHFFFAOYSA-N 2,4-dimethyl-6-pyridin-3-ylphenol Chemical compound CC1=CC(C)=C(O)C(C=2C=NC=CC=2)=C1 DLZPXTDIXNGPNS-UHFFFAOYSA-N 0.000 description 3
- LHCZWGADVPDJJP-UHFFFAOYSA-N 2,4-dimethyl-6-pyridin-4-ylphenol Chemical compound Cc1cc(C)c(O)c(c1)-c1ccncc1 LHCZWGADVPDJJP-UHFFFAOYSA-N 0.000 description 3
- PZJGUMIVROJMHA-UHFFFAOYSA-N 2-(2,4,6-trimethylphenyl)sulfanylacetohydrazide Chemical compound CC1=CC(C)=C(SCC(=O)NN)C(C)=C1 PZJGUMIVROJMHA-UHFFFAOYSA-N 0.000 description 3
- BXTXJUJFIBOLDD-UHFFFAOYSA-N 2-(2,6-dimethylphenoxy)acetohydrazide Chemical compound CC1=CC=CC(C)=C1OCC(=O)NN BXTXJUJFIBOLDD-UHFFFAOYSA-N 0.000 description 3
- OFXUGXFITTXQQP-UHFFFAOYSA-N 2-(2-ethyl-6-methylpyridin-3-yl)oxyacetohydrazide Chemical compound CCC1=NC(C)=CC=C1OCC(=O)NN OFXUGXFITTXQQP-UHFFFAOYSA-N 0.000 description 3
- WDGDFEOTIXZHMG-UHFFFAOYSA-N 2-(2-pyrrolidin-1-ylpyridin-3-yl)oxyacetohydrazide Chemical compound NNC(=O)COC1=CC=CN=C1N1CCCC1 WDGDFEOTIXZHMG-UHFFFAOYSA-N 0.000 description 3
- VEYRQNUYDHUSSA-UHFFFAOYSA-N 2-(2-tert-butyl-4-methoxyphenoxy)acetohydrazide Chemical compound COC1=CC=C(OCC(=O)NN)C(C(C)(C)C)=C1 VEYRQNUYDHUSSA-UHFFFAOYSA-N 0.000 description 3
- OREVCGAWPWQTGB-UHFFFAOYSA-N 2-(3-pyridin-3-ylphenoxy)acetohydrazide Chemical compound NNC(=O)COC1=CC=CC(C=2C=NC=CC=2)=C1 OREVCGAWPWQTGB-UHFFFAOYSA-N 0.000 description 3
- LAOAGPJYUSCGAI-UHFFFAOYSA-N 2-(4-fluoro-2-methylphenoxy)acetohydrazide Chemical compound CC1=CC(F)=CC=C1OCC(=O)NN LAOAGPJYUSCGAI-UHFFFAOYSA-N 0.000 description 3
- JJNMKKCUORDXDR-UHFFFAOYSA-N 2-[2,4-dimethyl-6-(oxan-4-yl)phenoxy]acetohydrazide Chemical compound CC1=CC(C)=C(OCC(=O)NN)C(C2CCOCC2)=C1 JJNMKKCUORDXDR-UHFFFAOYSA-N 0.000 description 3
- DXASQKKXESMUOH-UHFFFAOYSA-N 2-[2,4-dimethyl-6-(oxolan-2-yl)phenoxy]acetohydrazide Chemical compound CC1=CC(C)=C(OCC(=O)NN)C(C2OCCC2)=C1 DXASQKKXESMUOH-UHFFFAOYSA-N 0.000 description 3
- YPJRXZCYRPDVHT-UHFFFAOYSA-N 2-[2,6-di(propan-2-yl)phenoxy]acetohydrazide Chemical compound CC(C)C1=CC=CC(C(C)C)=C1OCC(=O)NN YPJRXZCYRPDVHT-UHFFFAOYSA-N 0.000 description 3
- CZZYAIIAXDTWEE-UHFFFAOYSA-N 2-bromo-4,6-dimethylphenol Chemical compound CC1=CC(C)=C(O)C(Br)=C1 CZZYAIIAXDTWEE-UHFFFAOYSA-N 0.000 description 3
- YKHQFTANTNMYPP-UHFFFAOYSA-N 2-bromopyridin-3-ol Chemical compound OC1=CC=CN=C1Br YKHQFTANTNMYPP-UHFFFAOYSA-N 0.000 description 3
- XEBUFEJCEKCQEK-UHFFFAOYSA-N 2-methyl-6-(oxolan-3-yl)phenol Chemical compound CC1=CC=CC(C2COCC2)=C1O XEBUFEJCEKCQEK-UHFFFAOYSA-N 0.000 description 3
- NGCGPAZCWNJTNW-UHFFFAOYSA-N 2-thiophen-3-ylpyridin-3-ol Chemical compound OC1=CC=CN=C1C1=CSC=C1 NGCGPAZCWNJTNW-UHFFFAOYSA-N 0.000 description 3
- SKMKJBYBPYBDMN-RYUDHWBXSA-N 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC(F)F)C(N)=NC=C1C1=CC(N2[C@H]3C[C@H](OC3)C2)=NC(N2CC(F)(F)CC2)=N1 SKMKJBYBPYBDMN-RYUDHWBXSA-N 0.000 description 3
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- CYEFKCRAAGLNHW-UHFFFAOYSA-N furan-3-ylboronic acid Chemical compound OB(O)C=1C=COC=1 CYEFKCRAAGLNHW-UHFFFAOYSA-N 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- SUYIARYAFWZKFU-UHFFFAOYSA-N methyl 2-(2,3-dimethylphenoxy)acetate Chemical compound COC(=O)COC1=CC=CC(C)=C1C SUYIARYAFWZKFU-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- GRJWOKACBGZOKT-UHFFFAOYSA-N 1,3-bis(chloromethyl)benzene Chemical compound ClCC1=CC=CC(CCl)=C1 GRJWOKACBGZOKT-UHFFFAOYSA-N 0.000 description 2
- XWVXMNKMVDFYMO-UHFFFAOYSA-N 1-(benzenesulfonyl)indole-6-carbaldehyde Chemical compound C12=CC(C=O)=CC=C2C=CN1S(=O)(=O)C1=CC=CC=C1 XWVXMNKMVDFYMO-UHFFFAOYSA-N 0.000 description 2
- QWBBPBRQALCEIZ-UHFFFAOYSA-N 2,3-dimethylphenol Chemical compound CC1=CC=CC(O)=C1C QWBBPBRQALCEIZ-UHFFFAOYSA-N 0.000 description 2
- NPMXVTFGVUVGNP-UHFFFAOYSA-N 2,4-dimethyl-6-thiophen-2-ylphenol Chemical compound CC1=CC(C)=C(O)C(C=2SC=CC=2)=C1 NPMXVTFGVUVGNP-UHFFFAOYSA-N 0.000 description 2
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- RVEPYPIFGURMKV-KKMKTNMSSA-N 2-(2,6-dimethyl-4-pyrimidin-5-ylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C(C)=CC=1C1=CN=CN=C1 RVEPYPIFGURMKV-KKMKTNMSSA-N 0.000 description 2
- MXFJGKUJIZDGDX-UHFFFAOYSA-N 2-(2,6-dimethyl-4-pyrimidin-5-ylphenoxy)acetohydrazide Chemical compound CC1=C(OCC(=O)NN)C(C)=CC(C=2C=NC=NC=2)=C1 MXFJGKUJIZDGDX-UHFFFAOYSA-N 0.000 description 2
- NIRZNTADKXZTAK-UHFFFAOYSA-N 2-(2,6-dimethylpyridin-4-yl)oxyacetohydrazide Chemical compound CC1=CC(OCC(=O)NN)=CC(C)=N1 NIRZNTADKXZTAK-UHFFFAOYSA-N 0.000 description 2
- YJVHSCFAKJDTAV-UHFFFAOYSA-N 2-(2,6-dimethylpyrimidin-4-yl)oxyacetohydrazide Chemical compound CC1=CC(OCC(=O)NN)=NC(C)=N1 YJVHSCFAKJDTAV-UHFFFAOYSA-N 0.000 description 2
- SUSZMLUYHPLSEX-UHFFFAOYSA-N 2-(2,6-ditert-butyl-4-methylphenoxy)acetohydrazide Chemical compound CC1=CC(C(C)(C)C)=C(OCC(=O)NN)C(C(C)(C)C)=C1 SUSZMLUYHPLSEX-UHFFFAOYSA-N 0.000 description 2
- KUNSDJWGBKKTMV-UHFFFAOYSA-N 2-(2-methylpyridin-3-yl)oxyacetohydrazide Chemical compound CC1=NC=CC=C1OCC(=O)NN KUNSDJWGBKKTMV-UHFFFAOYSA-N 0.000 description 2
- DEQVKYXYSDXYHW-UHFFFAOYSA-N 2-(2-pyridin-3-ylphenoxy)acetohydrazide Chemical compound NNC(=O)COC1=CC=CC=C1C1=CC=CN=C1 DEQVKYXYSDXYHW-UHFFFAOYSA-N 0.000 description 2
- DQYKZYZRDDNURW-UHFFFAOYSA-N 2-(4-bromo-2-cyanophenoxy)acetohydrazide Chemical compound NNC(=O)COC1=CC=C(Br)C=C1C#N DQYKZYZRDDNURW-UHFFFAOYSA-N 0.000 description 2
- QWPAKTONQSLHFT-UHFFFAOYSA-N 2-(furan-2-yl)-4,6-dimethylphenol Chemical compound CC1=CC(C)=C(O)C(C=2OC=CC=2)=C1 QWPAKTONQSLHFT-UHFFFAOYSA-N 0.000 description 2
- ISPUENCDHQTPNU-UHFFFAOYSA-N 2-(furan-3-yl)-4,6-dimethylphenol Chemical compound CC1=CC(C)=C(O)C(C2=COC=C2)=C1 ISPUENCDHQTPNU-UHFFFAOYSA-N 0.000 description 2
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 description 2
- LBHWSOBPFIPRNR-DHRITJCHSA-N 2-[2,4-dimethyl-6-(oxolan-2-yl)phenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C=1C1CCCO1 LBHWSOBPFIPRNR-DHRITJCHSA-N 0.000 description 2
- HZMQQBZLCWLYBK-BRJLIKDPSA-N 2-[2,4-dimethyl-6-(oxolan-3-yl)phenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C=1C1CCOC1 HZMQQBZLCWLYBK-BRJLIKDPSA-N 0.000 description 2
- LCLWAZZVCBWOSE-BRJLIKDPSA-N 2-[2,6-dimethyl-4-(oxolan-3-yl)phenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C(C)=CC=1C1CCOC1 LCLWAZZVCBWOSE-BRJLIKDPSA-N 0.000 description 2
- HPFZDYWIPBBWQM-UHFFFAOYSA-N 2-[2,6-dimethyl-4-(oxolan-3-yl)phenoxy]acetohydrazide Chemical compound CC1=C(OCC(=O)NN)C(C)=CC(C2COCC2)=C1 HPFZDYWIPBBWQM-UHFFFAOYSA-N 0.000 description 2
- GPGKNBRGUFRSHS-BRJLIKDPSA-N 2-[4-(furan-3-yl)-2,6-dimethylphenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C(C)=CC=1C=1C=COC=1 GPGKNBRGUFRSHS-BRJLIKDPSA-N 0.000 description 2
- HFQXGCGVJRWFNT-OPEKNORGSA-N 2-[4-fluoro-2-methyl-6-(oxolan-3-yl)phenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/NC(=O)COC=1C(C)=CC(F)=CC=1C1CCOC1 HFQXGCGVJRWFNT-OPEKNORGSA-N 0.000 description 2
- AQSRRZGQRFFFGS-UHFFFAOYSA-N 2-methylpyridin-3-ol Chemical compound CC1=NC=CC=C1O AQSRRZGQRFFFGS-UHFFFAOYSA-N 0.000 description 2
- NZUFQZYLLCLCAE-UHFFFAOYSA-N 4-(2-aminopyrimidin-5-yl)-2,6-dimethylphenol Chemical compound CC1=C(O)C(C)=CC(C=2C=NC(N)=NC=2)=C1 NZUFQZYLLCLCAE-UHFFFAOYSA-N 0.000 description 2
- XWQVQSXLXAXOPJ-QNGMFEMESA-N 4-[[[6-[5-chloro-2-[[4-[[(2r)-1-methoxypropan-2-yl]amino]cyclohexyl]amino]pyridin-4-yl]pyridin-2-yl]amino]methyl]oxane-4-carbonitrile Chemical compound C1CC(N[C@H](C)COC)CCC1NC1=CC(C=2N=C(NCC3(CCOCC3)C#N)C=CC=2)=C(Cl)C=N1 XWQVQSXLXAXOPJ-QNGMFEMESA-N 0.000 description 2
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 2
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000002508 compound effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 108700003601 dimethylglycine Proteins 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 229940125721 immunosuppressive agent Drugs 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- AAECFYTVKCDWQU-UHFFFAOYSA-N methyl 2-(2,4,6-trimethylphenyl)sulfanylacetate Chemical compound COC(=O)CSC1=C(C)C=C(C)C=C1C AAECFYTVKCDWQU-UHFFFAOYSA-N 0.000 description 2
- LXKNFFSMAVWXOF-UHFFFAOYSA-N methyl 2-(2,6-dimethylphenoxy)acetate Chemical compound COC(=O)COC1=C(C)C=CC=C1C LXKNFFSMAVWXOF-UHFFFAOYSA-N 0.000 description 2
- XJUKXDZQJSOFLV-UHFFFAOYSA-N methyl 2-(2,6-dimethylpyrimidin-4-yl)oxyacetate Chemical compound COC(=O)COC1=CC(C)=NC(C)=N1 XJUKXDZQJSOFLV-UHFFFAOYSA-N 0.000 description 2
- PLQNJPNAEJRYMR-UHFFFAOYSA-N methyl 2-(2,6-ditert-butyl-4-methylphenoxy)acetate Chemical compound COC(=O)COC1=C(C(C)(C)C)C=C(C)C=C1C(C)(C)C PLQNJPNAEJRYMR-UHFFFAOYSA-N 0.000 description 2
- OBWIVXWDOUFFOO-UHFFFAOYSA-N methyl 2-(2-ethyl-6-methylpyridin-3-yl)oxyacetate Chemical compound CCC1=NC(C)=CC=C1OCC(=O)OC OBWIVXWDOUFFOO-UHFFFAOYSA-N 0.000 description 2
- DUBJVRLPNDUZBY-UHFFFAOYSA-N methyl 2-(2-pyridin-3-ylphenoxy)acetate Chemical compound COC(=O)COC1=CC=CC=C1C1=CC=CN=C1 DUBJVRLPNDUZBY-UHFFFAOYSA-N 0.000 description 2
- WRGLKRKQPPJNMB-UHFFFAOYSA-N methyl 2-(2-pyrrolidin-1-ylpyridin-3-yl)oxyacetate Chemical compound COC(=O)COC1=CC=CN=C1N1CCCC1 WRGLKRKQPPJNMB-UHFFFAOYSA-N 0.000 description 2
- XWHJAKLGLRAIOY-UHFFFAOYSA-N methyl 2-(2-tert-butyl-4-methoxyphenoxy)acetate Chemical compound COC(=O)COC1=CC=C(OC)C=C1C(C)(C)C XWHJAKLGLRAIOY-UHFFFAOYSA-N 0.000 description 2
- GIFPKKADQXWDEM-UHFFFAOYSA-N methyl 2-(4-bromo-2,6-dimethylphenoxy)acetate Chemical compound COC(=O)COC1=C(C)C=C(Br)C=C1C GIFPKKADQXWDEM-UHFFFAOYSA-N 0.000 description 2
- FSQBHEGGTFKQFX-UHFFFAOYSA-N methyl 2-(4-bromo-2-cyanophenoxy)acetate Chemical compound COC(=O)COC1=CC=C(Br)C=C1C#N FSQBHEGGTFKQFX-UHFFFAOYSA-N 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 2
- HYHKNTQKTKRMHQ-SSDVNMTOSA-N n-[(e)-1h-indol-4-ylmethylideneamino]-2-(2,4,6-trimethylphenyl)sulfanylacetamide Chemical compound CC1=CC(C)=CC(C)=C1SCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 HYHKNTQKTKRMHQ-SSDVNMTOSA-N 0.000 description 2
- WKORVFGZQMFNJW-AFUMVMLFSA-N n-[(e)-1h-indol-4-ylmethylideneamino]-2-(2-pyridin-3-ylphenoxy)acetamide Chemical compound C=1C=CC=2NC=CC=2C=1/C=N/NC(=O)COC1=CC=CC=C1C1=CC=CN=C1 WKORVFGZQMFNJW-AFUMVMLFSA-N 0.000 description 2
- MNAWPVAVDFGGFD-YDZHTSKRSA-N n-[(e)-1h-indol-6-ylmethylideneamino]-2-(2-pyrrolidin-1-ylpyridin-3-yl)oxyacetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/NC(=O)COC1=CC=CN=C1N1CCCC1 MNAWPVAVDFGGFD-YDZHTSKRSA-N 0.000 description 2
- 239000008389 polyethoxylated castor oil Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PKANQZUPJCMBAK-UHFFFAOYSA-N 2,4,6-trimethylbenzenethiol Chemical compound CC1=CC(C)=C(S)C(C)=C1 PKANQZUPJCMBAK-UHFFFAOYSA-N 0.000 description 1
- XDFHWZTUEABHHL-UHFFFAOYSA-N 2,4-dimethyl-6-(oxan-4-yl)phenol Chemical compound CC1=CC(C)=C(O)C(C2CCOCC2)=C1 XDFHWZTUEABHHL-UHFFFAOYSA-N 0.000 description 1
- PMCOWOCKUQWYRL-UHFFFAOYSA-N 2,4-dimethylpyrimidine Chemical compound CC1=CC=NC(C)=N1 PMCOWOCKUQWYRL-UHFFFAOYSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- PRAFLUMTYHBEHE-UHFFFAOYSA-N 2,6-dimethyl-1h-pyridin-4-one Chemical compound CC1=CC(O)=CC(C)=N1 PRAFLUMTYHBEHE-UHFFFAOYSA-N 0.000 description 1
- UQFHLJKWYIJISA-UHFFFAOYSA-N 2,6-dimethyl-1h-pyrimidin-4-one Chemical compound CC1=CC(O)=NC(C)=N1 UQFHLJKWYIJISA-UHFFFAOYSA-N 0.000 description 1
- ZTHZOEJSVDJJSX-UHFFFAOYSA-N 2,6-dimethyl-4-pyrimidin-5-ylphenol Chemical compound CC1=C(O)C(C)=CC(C=2C=NC=NC=2)=C1 ZTHZOEJSVDJJSX-UHFFFAOYSA-N 0.000 description 1
- KQAXOOFUDVRGPK-SRZZPIQSSA-N 2-(2,3-dimethylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=CC=CC(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)=C1C KQAXOOFUDVRGPK-SRZZPIQSSA-N 0.000 description 1
- SNQBLPRHSBIBDC-MZJWZYIUSA-N 2-(2,4-dimethyl-6-pyridin-3-ylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C1=CC=CN=C1 SNQBLPRHSBIBDC-MZJWZYIUSA-N 0.000 description 1
- IXONTMWPQNWLMA-UVHMKAGCSA-N 2-(2,4-dimethyl-6-pyridin-3-ylphenoxy)-n-[(e)-1h-indol-5-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3C=CNC3=CC=2)C=1C1=CC=CN=C1 IXONTMWPQNWLMA-UVHMKAGCSA-N 0.000 description 1
- GXBHHCVDJDCTBS-UVHMKAGCSA-N 2-(2,4-dimethyl-6-pyridin-3-ylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C=1C1=CC=CN=C1 GXBHHCVDJDCTBS-UVHMKAGCSA-N 0.000 description 1
- LCUWOSRYUVSZGE-MZJWZYIUSA-N 2-(2,4-dimethyl-6-pyridin-4-ylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C=1C1=CC=NC=C1 LCUWOSRYUVSZGE-MZJWZYIUSA-N 0.000 description 1
- BTECGOKEHBHGBV-DHRITJCHSA-N 2-(2,4-dimethyl-6-thiophen-2-ylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C1=CC=CS1 BTECGOKEHBHGBV-DHRITJCHSA-N 0.000 description 1
- JRVOZXLULWIOIJ-MZJWZYIUSA-N 2-(2,6-dimethyl-4-pyridin-2-ylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C(C)=CC=1C1=CC=CC=N1 JRVOZXLULWIOIJ-MZJWZYIUSA-N 0.000 description 1
- BGJXFMJJKVMLLP-SRZZPIQSSA-N 2-(2,6-dimethylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=CC=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 BGJXFMJJKVMLLP-SRZZPIQSSA-N 0.000 description 1
- IZYUKXYAIOWHNT-SRZZPIQSSA-N 2-(2,6-dimethylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound CC1=CC=CC(C)=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 IZYUKXYAIOWHNT-SRZZPIQSSA-N 0.000 description 1
- HPXGDIKLAUYWFD-KEBDBYFISA-N 2-(2,6-dimethylpyridin-4-yl)oxy-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=NC(C)=CC(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)=C1 HPXGDIKLAUYWFD-KEBDBYFISA-N 0.000 description 1
- DNIZJQPCLUCCFU-DJKKODMXSA-N 2-(2,6-dimethylpyrimidin-4-yl)oxy-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=NC(C)=CC(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)=N1 DNIZJQPCLUCCFU-DJKKODMXSA-N 0.000 description 1
- OPIUELFGAWWOKF-RWPZCVJISA-N 2-(2,6-ditert-butyl-4-methylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC(C)(C)C1=CC(C)=CC(C(C)(C)C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 OPIUELFGAWWOKF-RWPZCVJISA-N 0.000 description 1
- CBHKDRNCVUFHEJ-LSHDLFTRSA-N 2-(2-bromo-4,6-dimethylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound BrC1=CC(C)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 CBHKDRNCVUFHEJ-LSHDLFTRSA-N 0.000 description 1
- ZTFJTYVVQFTIKR-LSHDLFTRSA-N 2-(2-bromo-4,6-dimethylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound BrC1=CC(C)=CC(C)=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 ZTFJTYVVQFTIKR-LSHDLFTRSA-N 0.000 description 1
- AASQHLMSLQCBLR-UHFFFAOYSA-N 2-(2-bromo-4,6-dimethylphenoxy)acetohydrazide Chemical compound CC1=CC(C)=C(OCC(=O)NN)C(Br)=C1 AASQHLMSLQCBLR-UHFFFAOYSA-N 0.000 description 1
- CEUCGLZLWAHVHB-SRZZPIQSSA-N 2-(2-ethyl-6-methylpyridin-3-yl)oxy-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CCC1=NC(C)=CC=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 CEUCGLZLWAHVHB-SRZZPIQSSA-N 0.000 description 1
- IZKZWXPJJKPOGW-SRZZPIQSSA-N 2-(2-ethyl-6-methylpyridin-3-yl)oxy-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound CCC1=NC(C)=CC=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 IZKZWXPJJKPOGW-SRZZPIQSSA-N 0.000 description 1
- KNRKUAGSGSZABX-ZMOGYAJESA-N 2-(2-tert-butyl-4-methoxyphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC(C)(C)C1=CC(OC)=CC=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 KNRKUAGSGSZABX-ZMOGYAJESA-N 0.000 description 1
- TXJLVDJLVGFFAP-LSHDLFTRSA-N 2-(4-amino-2,6-dimethylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=CC(N)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 TXJLVDJLVGFFAP-LSHDLFTRSA-N 0.000 description 1
- KQROKMUCDUVDLG-LSHDLFTRSA-N 2-(4-bromo-2,6-dimethylphenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=CC(Br)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 KQROKMUCDUVDLG-LSHDLFTRSA-N 0.000 description 1
- QHZGNYUQJGAKSG-LSHDLFTRSA-N 2-(4-bromo-2-cyanophenoxy)-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound N#CC1=CC(Br)=CC=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 QHZGNYUQJGAKSG-LSHDLFTRSA-N 0.000 description 1
- AIBKZOAOZXWOLS-FOKLQQMPSA-N 2-(4-cyano-2,6-dimethylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound CC1=CC(C#N)=CC(C)=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 AIBKZOAOZXWOLS-FOKLQQMPSA-N 0.000 description 1
- SLYIMODTBWYYHP-UFFVCSGVSA-N 2-(4-fluoro-2-methylphenoxy)-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound CC1=CC(F)=CC=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 SLYIMODTBWYYHP-UFFVCSGVSA-N 0.000 description 1
- FEMZNCCKLDJASQ-BRJLIKDPSA-N 2-[2,4-dimethyl-6-(oxolan-3-yl)phenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C1CCOC1 FEMZNCCKLDJASQ-BRJLIKDPSA-N 0.000 description 1
- RVPFJHHFKASNQX-UHFFFAOYSA-N 2-[2,4-dimethyl-6-(oxolan-3-yl)phenoxy]acetohydrazide Chemical compound CC1=CC(C)=C(OCC(=O)NN)C(C2COCC2)=C1 RVPFJHHFKASNQX-UHFFFAOYSA-N 0.000 description 1
- LXIQQTRGIPJWNL-DHRITJCHSA-N 2-[2,6-di(propan-2-yl)phenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC(C)C1=CC=CC(C(C)C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 LXIQQTRGIPJWNL-DHRITJCHSA-N 0.000 description 1
- UZIQBIWTRQLWRJ-BRJLIKDPSA-N 2-[2,6-dimethyl-4-(oxolan-3-yl)phenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C(C)=CC=1C1CCOC1 UZIQBIWTRQLWRJ-BRJLIKDPSA-N 0.000 description 1
- RZMFMXDZAUWQLW-DHRITJCHSA-N 2-[2-(furan-2-yl)-4,6-dimethylphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C1=CC=CO1 RZMFMXDZAUWQLW-DHRITJCHSA-N 0.000 description 1
- BJMFEUJQURNKMY-ZMOGYAJESA-N 2-[2-(furan-2-yl)-4-methoxyphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(OC)=CC=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C1=CC=CO1 BJMFEUJQURNKMY-ZMOGYAJESA-N 0.000 description 1
- JSTPEJJJBWYZGS-BRJLIKDPSA-N 2-[2-(furan-3-yl)-4,6-dimethylphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C=1C=1C=COC=1 JSTPEJJJBWYZGS-BRJLIKDPSA-N 0.000 description 1
- ZBPNXZMMSDHVJB-BRJLIKDPSA-N 2-[2-(furan-3-yl)-4,6-dimethylphenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C(C)=CC(C)=C(OCC(=O)N\N=C\C=2C=C3NC=CC3=CC=2)C=1C=1C=COC=1 ZBPNXZMMSDHVJB-BRJLIKDPSA-N 0.000 description 1
- VNKIRGRPUBSGCL-UHFFFAOYSA-N 2-[2-(furan-3-yl)-4,6-dimethylphenoxy]acetohydrazide Chemical compound CC1=CC(C)=C(OCC(=O)NN)C(C2=COC=C2)=C1 VNKIRGRPUBSGCL-UHFFFAOYSA-N 0.000 description 1
- NGRNIHQODNCPDD-WYMPLXKRSA-N 2-[2-(furan-3-yl)-6-methylphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C=CC=2NC=CC=2C=1/C=N/NC(=O)COC=1C(C)=CC=CC=1C=1C=COC=1 NGRNIHQODNCPDD-WYMPLXKRSA-N 0.000 description 1
- FQHNOTRVIRNQIY-WYMPLXKRSA-N 2-[2-(furan-3-yl)-6-methylphenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/NC(=O)COC=1C(C)=CC=CC=1C=1C=COC=1 FQHNOTRVIRNQIY-WYMPLXKRSA-N 0.000 description 1
- ITICSIUQZSTMNR-FOKLQQMPSA-N 2-[2-(furan-3-yl)pyridin-3-yl]oxy-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C=CC=2NC=CC=2C=1/C=N/NC(=O)COC1=CC=CN=C1C=1C=COC=1 ITICSIUQZSTMNR-FOKLQQMPSA-N 0.000 description 1
- PARZGEUHBBBYSD-BRJLIKDPSA-N 2-[4-(furan-3-yl)-2,6-dimethylphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound C=1C(C)=C(OCC(=O)N\N=C\C=2C=3C=CNC=3C=CC=2)C(C)=CC=1C=1C=COC=1 PARZGEUHBBBYSD-BRJLIKDPSA-N 0.000 description 1
- AYJCCXJAHGUNEL-LSHDLFTRSA-N 2-[4-(hydroxymethyl)-2,6-dimethylphenoxy]-n-[(e)-1h-indol-4-ylmethylideneamino]acetamide Chemical compound CC1=CC(CO)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 AYJCCXJAHGUNEL-LSHDLFTRSA-N 0.000 description 1
- XSLJCAYNCWIWFN-LSHDLFTRSA-N 2-[4-(hydroxymethyl)-2,6-dimethylphenoxy]-n-[(e)-1h-indol-6-ylmethylideneamino]acetamide Chemical compound CC1=CC(CO)=CC(C)=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 XSLJCAYNCWIWFN-LSHDLFTRSA-N 0.000 description 1
- FNZCVKFNRGGISF-LGJNPRDNSA-N 2-[4-fluoro-2-methyl-6-(oxolan-3-yl)phenoxy]-n-methyl-n-[(e)-(1-methylindol-6-yl)methylideneamino]acetamide Chemical compound C=1C=C2C=CN(C)C2=CC=1/C=N/N(C)C(=O)COC1=C(C)C=C(F)C=C1C1CCOC1 FNZCVKFNRGGISF-LGJNPRDNSA-N 0.000 description 1
- CRFKFEAHGVZUFU-UHFFFAOYSA-N 2-bromo-4-fluoro-6-methylphenol Chemical compound CC1=CC(F)=CC(Br)=C1O CRFKFEAHGVZUFU-UHFFFAOYSA-N 0.000 description 1
- YXZPTVOCJLCMRO-UHFFFAOYSA-N 2-bromo-6-methylphenol Chemical compound CC1=CC=CC(Br)=C1O YXZPTVOCJLCMRO-UHFFFAOYSA-N 0.000 description 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- QSECPQCFCWVBKM-UHFFFAOYSA-N 2-iodoethanol Chemical compound OCCI QSECPQCFCWVBKM-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- ZLVFYUORUHNMBO-UHFFFAOYSA-N 4-bromo-2,6-dimethylphenol Chemical compound CC1=CC(Br)=CC(C)=C1O ZLVFYUORUHNMBO-UHFFFAOYSA-N 0.000 description 1
- GKQDDKKGDIVDAG-UHFFFAOYSA-N 4-fluoro-2-methylphenol Chemical compound CC1=CC(F)=CC=C1O GKQDDKKGDIVDAG-UHFFFAOYSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- PVCONXMDUZOPJH-UHFFFAOYSA-N 5-bromo-2-hydroxybenzonitrile Chemical compound OC1=CC=C(Br)C=C1C#N PVCONXMDUZOPJH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000004736 B-Cell Leukemia Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- KDPAWGWELVVRCH-UHFFFAOYSA-M bromoacetate Chemical compound [O-]C(=O)CBr KDPAWGWELVVRCH-UHFFFAOYSA-M 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- JGPOSNWWINVNFV-UHFFFAOYSA-N carboxyfluorescein diacetate succinimidyl ester Chemical compound C=1C(OC(=O)C)=CC=C2C=1OC1=CC(OC(C)=O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O JGPOSNWWINVNFV-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- JPGDYIGSCHWQCC-UHFFFAOYSA-N emoxypine Chemical compound CCC1=NC(C)=CC=C1O JPGDYIGSCHWQCC-UHFFFAOYSA-N 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- MWNPUHLLRZYBMK-UHFFFAOYSA-N methyl 2-(2,6-dimethyl-4-pyrimidin-5-ylphenoxy)acetate Chemical compound C1=C(C)C(OCC(=O)OC)=C(C)C=C1C1=CN=CN=C1 MWNPUHLLRZYBMK-UHFFFAOYSA-N 0.000 description 1
- AMYZFMGHRGSXKY-UHFFFAOYSA-N methyl 2-[2,4-dimethyl-6-(oxolan-2-yl)phenoxy]acetate Chemical compound COC(=O)COC1=C(C)C=C(C)C=C1C1OCCC1 AMYZFMGHRGSXKY-UHFFFAOYSA-N 0.000 description 1
- NSJZPVMCXDGEGK-UHFFFAOYSA-N methyl 2-[2,6-di(propan-2-yl)phenoxy]acetate Chemical compound COC(=O)COC1=C(C(C)C)C=CC=C1C(C)C NSJZPVMCXDGEGK-UHFFFAOYSA-N 0.000 description 1
- BTAISCAHWHKVGX-UHFFFAOYSA-N methyl 2-[2,6-dimethyl-4-(oxolan-3-yl)phenoxy]acetate Chemical compound C1=C(C)C(OCC(=O)OC)=C(C)C=C1C1COCC1 BTAISCAHWHKVGX-UHFFFAOYSA-N 0.000 description 1
- OLKAYXOHRRJWJO-UHFFFAOYSA-N methyl 2-[2-(furan-3-yl)pyridin-3-yl]oxyacetate Chemical compound COC(=O)COC1=CC=CN=C1C1=COC=C1 OLKAYXOHRRJWJO-UHFFFAOYSA-N 0.000 description 1
- AMFAZCNPMLSBIJ-UHFFFAOYSA-N methyl 2-[4-(2-aminopyrimidin-5-yl)-2,6-dimethylphenoxy]acetate Chemical compound C1=C(C)C(OCC(=O)OC)=C(C)C=C1C1=CN=C(N)N=C1 AMFAZCNPMLSBIJ-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- XPGMJSSKPMBIMU-KEBDBYFISA-N n-[(e)-1h-indol-4-ylmethylideneamino]-2-(2-methylpyridin-3-yl)oxyacetamide Chemical compound CC1=NC=CC=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2 XPGMJSSKPMBIMU-KEBDBYFISA-N 0.000 description 1
- JRMLRSKPRSIJJZ-AFUMVMLFSA-N n-[(e)-1h-indol-4-ylmethylideneamino]-2-(3-pyridin-3-ylphenoxy)acetamide Chemical compound C=1C=CC=2NC=CC=2C=1/C=N/NC(=O)COC(C=1)=CC=CC=1C1=CC=CN=C1 JRMLRSKPRSIJJZ-AFUMVMLFSA-N 0.000 description 1
- HOCUYHIHQSFODI-WYMPLXKRSA-N n-[(e)-1h-indol-4-ylmethylideneamino]-2-[2-methyl-6-(oxolan-3-yl)phenoxy]acetamide Chemical compound C=1C=CC=2NC=CC=2C=1/C=N/NC(=O)COC=1C(C)=CC=CC=1C1CCOC1 HOCUYHIHQSFODI-WYMPLXKRSA-N 0.000 description 1
- YSTNSFVRZDITJB-SSDVNMTOSA-N n-[(e)-1h-indol-6-ylmethylideneamino]-2-(2,4,6-trimethylphenyl)sulfanylacetamide Chemical compound CC1=CC(C)=CC(C)=C1SCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 YSTNSFVRZDITJB-SSDVNMTOSA-N 0.000 description 1
- NMNIGQUJUXTUDG-KEBDBYFISA-N n-[(e)-1h-indol-6-ylmethylideneamino]-2-(2-methylpyridin-3-yl)oxyacetamide Chemical compound CC1=NC=CC=C1OCC(=O)N\N=C\C1=CC=C(C=CN2)C2=C1 NMNIGQUJUXTUDG-KEBDBYFISA-N 0.000 description 1
- KWDJHTRIXPTAAH-FOKLQQMPSA-N n-[(e)-1h-indol-6-ylmethylideneamino]-2-(2-thiophen-3-ylpyridin-3-yl)oxyacetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/NC(=O)COC1=CC=CN=C1C=1C=CSC=1 KWDJHTRIXPTAAH-FOKLQQMPSA-N 0.000 description 1
- INPQNDBCJGHKST-WYMPLXKRSA-N n-[(e)-1h-indol-6-ylmethylideneamino]-2-[2-methyl-6-(oxolan-3-yl)phenoxy]acetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/NC(=O)COC=1C(C)=CC=CC=1C1CCOC1 INPQNDBCJGHKST-WYMPLXKRSA-N 0.000 description 1
- RZNYPQHLBRWLQE-YDZHTSKRSA-N n-[(e)-[1-(2-hydroxyethyl)indol-4-yl]methylideneamino]-2-(2,4,6-trimethylphenoxy)acetamide Chemical compound CC1=CC(C)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2CCO RZNYPQHLBRWLQE-YDZHTSKRSA-N 0.000 description 1
- XUCDWTMLBVVUSE-JVWAILMASA-N n-[(e)-[1-(benzenesulfonyl)indol-4-yl]methylideneamino]-2-(2,4,6-trimethylphenoxy)acetamide Chemical compound CC1=CC(C)=CC(C)=C1OCC(=O)N\N=C\C1=CC=CC2=C1C=CN2S(=O)(=O)C1=CC=CC=C1 XUCDWTMLBVVUSE-JVWAILMASA-N 0.000 description 1
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 description 1
- PLULVNOGTQRBCY-WYMPLXKRSA-N n-acetyl-n-[(e)-1h-indol-6-ylmethylideneamino]-2-(2,4,6-trimethylphenoxy)acetamide Chemical compound C=1C=C2C=CNC2=CC=1/C=N/N(C(=O)C)C(=O)COC1=C(C)C=C(C)C=C1C PLULVNOGTQRBCY-WYMPLXKRSA-N 0.000 description 1
- FKBZQCIPUZHQML-YDZHTSKRSA-N n-methyl-n-[(e)-(1-methylindol-4-yl)methylideneamino]-2-(2,4,6-trimethylphenoxy)acetamide Chemical compound C=1C=CC=2N(C)C=CC=2C=1/C=N/N(C)C(=O)COC1=C(C)C=C(C)C=C1C FKBZQCIPUZHQML-YDZHTSKRSA-N 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000861 pro-apoptotic effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- UMLDUMMLRZFROX-UHFFFAOYSA-N pyridin-2-ylboronic acid Chemical compound OB(O)C1=CC=CC=N1 UMLDUMMLRZFROX-UHFFFAOYSA-N 0.000 description 1
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 1
- QNMBSXGYAQZCTN-UHFFFAOYSA-N thiophen-3-ylboronic acid Chemical compound OB(O)C=1C=CSC=1 QNMBSXGYAQZCTN-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120095729 | 2012-08-30 | ||
| KR20120095729 | 2012-08-30 | ||
| KR20120108972 | 2012-09-28 | ||
| KR20120108972 | 2012-09-28 | ||
| PCT/KR2013/007751 WO2014035149A1 (en) | 2012-08-30 | 2013-08-29 | N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2651312T3 true ES2651312T3 (es) | 2018-01-25 |
Family
ID=50183887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13833207.7T Active ES2651312T3 (es) | 2012-08-30 | 2013-08-29 | Derivados de N-acilhidrazona para un fármaco inhibidor selectivo de células T y contra la neoplasia linfoide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9447083B2 (OSRAM) |
| EP (1) | EP2890677B1 (OSRAM) |
| JP (1) | JP6139682B2 (OSRAM) |
| KR (1) | KR101561987B1 (OSRAM) |
| CN (1) | CN104755460B (OSRAM) |
| AU (1) | AU2013309723B2 (OSRAM) |
| BR (1) | BR112015004432A2 (OSRAM) |
| CA (1) | CA2881797C (OSRAM) |
| ES (1) | ES2651312T3 (OSRAM) |
| IN (1) | IN2015MN00411A (OSRAM) |
| MX (1) | MX368381B (OSRAM) |
| NZ (1) | NZ704807A (OSRAM) |
| PH (1) | PH12015500282B1 (OSRAM) |
| RU (1) | RU2622651C2 (OSRAM) |
| WO (1) | WO2014035149A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106986789B (zh) * | 2016-01-20 | 2019-07-16 | 中国人民解放军军事医学科学院生物医学分析中心 | 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用 |
| EP3851519A4 (en) * | 2018-09-28 | 2021-12-29 | Nissan Chemical Corporation | Additive for medium for promoting production of paracrine factor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| DE102004037515A1 (de) | 2003-08-22 | 2005-03-17 | Merck Patent Gmbh | Verfahren zur Herstellung von Aldehyden |
| EP1885361A2 (en) * | 2005-05-06 | 2008-02-13 | Boehringer Ingelheim International GmbH | Acyl hydrazones for treating cardiovascular diseases |
| US8283351B2 (en) * | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
| US8642660B2 (en) | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009155362A1 (en) * | 2008-06-19 | 2009-12-23 | Ligand Pharmaceuticals Inc. | Small molecule hematopoietic growth factor mimetic compounds and their uses |
| WO2013032907A1 (en) | 2011-08-26 | 2013-03-07 | The Broad Institute, Inc. | Compounds and methods for the treatment of cancer stem cells |
-
2013
- 2013-08-29 WO PCT/KR2013/007751 patent/WO2014035149A1/en not_active Ceased
- 2013-08-29 US US14/424,749 patent/US9447083B2/en not_active Expired - Fee Related
- 2013-08-29 NZ NZ704807A patent/NZ704807A/en not_active IP Right Cessation
- 2013-08-29 AU AU2013309723A patent/AU2013309723B2/en not_active Ceased
- 2013-08-29 EP EP13833207.7A patent/EP2890677B1/en not_active Not-in-force
- 2013-08-29 RU RU2015105511A patent/RU2622651C2/ru active
- 2013-08-29 JP JP2015529676A patent/JP6139682B2/ja not_active Expired - Fee Related
- 2013-08-29 ES ES13833207.7T patent/ES2651312T3/es active Active
- 2013-08-29 IN IN411MUN2015 patent/IN2015MN00411A/en unknown
- 2013-08-29 CN CN201380056385.7A patent/CN104755460B/zh not_active Expired - Fee Related
- 2013-08-29 MX MX2015002601A patent/MX368381B/es active IP Right Grant
- 2013-08-29 BR BR112015004432A patent/BR112015004432A2/pt not_active Application Discontinuation
- 2013-08-29 CA CA2881797A patent/CA2881797C/en not_active Expired - Fee Related
- 2013-08-30 KR KR1020130103747A patent/KR101561987B1/ko not_active Expired - Fee Related
-
2015
- 2015-02-09 PH PH12015500282A patent/PH12015500282B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140029318A (ko) | 2014-03-10 |
| JP6139682B2 (ja) | 2017-05-31 |
| PH12015500282A1 (en) | 2015-04-27 |
| KR101561987B1 (ko) | 2015-10-20 |
| EP2890677A4 (en) | 2016-03-09 |
| US9447083B2 (en) | 2016-09-20 |
| RU2015105511A (ru) | 2016-10-20 |
| PH12015500282B1 (en) | 2015-04-27 |
| CN104755460A (zh) | 2015-07-01 |
| MX2015002601A (es) | 2015-09-29 |
| EP2890677A1 (en) | 2015-07-08 |
| IN2015MN00411A (OSRAM) | 2015-09-04 |
| NZ704807A (en) | 2016-06-24 |
| CN104755460B (zh) | 2017-05-10 |
| AU2013309723B2 (en) | 2016-07-14 |
| RU2622651C2 (ru) | 2017-06-19 |
| BR112015004432A2 (pt) | 2017-07-04 |
| WO2014035149A1 (en) | 2014-03-06 |
| EP2890677B1 (en) | 2017-11-15 |
| MX368381B (es) | 2019-09-30 |
| CA2881797A1 (en) | 2014-03-06 |
| CA2881797C (en) | 2017-08-01 |
| AU2013309723A1 (en) | 2015-02-26 |
| US20150252030A1 (en) | 2015-09-10 |
| JP2015526508A (ja) | 2015-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2244733T3 (es) | Derivados de n-adamantilalquil-benzamida como antagonistas del receptor p2x7. | |
| ES2655855T4 (es) | Derivados de piperidinil-indol y su uso como inhibidores del factor de complemento B | |
| ES2816060T3 (es) | Aza-aril 1H-pirazol-1-il-bencenosulfonamidas como antagonistas de CCR(9) | |
| ES2694829T3 (es) | Derivados de benzotriazol trisustituido como inhibidores de dihidroorotato oxigenasa | |
| ES2927346T3 (es) | Inhibidores de HPK1, método de preparación y aplicación de los mismos | |
| ES3050217T3 (en) | Tricyclic parp1 inhibitors and uses thereof | |
| ES2714100T3 (es) | Compuestos de quinolina fusionados como inhibidores de mTor, pi3k | |
| JP6615207B2 (ja) | 複素環式化合物及びその使用 | |
| EA021613B1 (ru) | Азабензимидазолы в качестве противовирусных средств в отношении респираторного синцитиального вируса | |
| PT98673B (pt) | Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios | |
| ES3059451T3 (en) | Compound used as ret kinase inhibitor and application thereof | |
| JP2020189852A (ja) | キナーゼ阻害活性を有するベンズヒドロール−ピラゾール誘導体及びその使用 | |
| JP7157462B2 (ja) | 熱ショックタンパク質９０阻害剤 | |
| ES2890552T3 (es) | Compuestos de pirimidina sustituidos y su uso como inhibidores de SYK | |
| ES2935615T3 (es) | Azetidina dihidrotienopiridinas sustituidas y su uso como inhibidores de la fosfodiesterasa | |
| KR20260035804A (ko) | 항바이러스 헤테로사이클릭 화합물 | |
| KR20220110744A (ko) | 암 줄기 세포를 표적화하는 암 치료 | |
| ES2848699T3 (es) | Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2 | |
| ES2849153T3 (es) | 2H-Selenofeno[3,2-h]cromenos antimetastásicos, síntesis de los mismos, y métodos de uso de tales agentes | |
| ES2937789T3 (es) | Activadores de AMPK directos de benzimidazol | |
| ES2647262T3 (es) | Derivado de alquinil indazol y uso del mismo | |
| KR101872264B1 (ko) | 신규한 유형의 시티딘 유도체 이량체 및 그의 용도 | |
| WO2021062319A1 (en) | Indole carboxamide compounds and use thereof for the treatment of mycobacterial infections | |
| AU2013309723B2 (en) | N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug | |
| TW202442227A (zh) | 一種環戊基吡唑胺衍生物及其用途 |